Plasma high-sensitivity troponin T predicts end-stage renal disease and cardiovascular and all-cause mortality in patients with type 1 diabetes and diabetic nephropathy
- 14 July 2017
- journal article
- research article
- Published by Elsevier in Kidney International
- Vol. 92 (5) , 1242-1248
Abstract
No abstract availableKeywords
This publication has 17 references indexed in Scilit:
- Association between blood glucose levels and high-sensitivity cardiac troponin T in an overt cardiovascular disease-free community-based studyDiabetes Research and Clinical Practice, 2012
- High-sensitive troponin T and N-terminal pro-B type natriuretic peptide are associated with cardiovascular events despite the cross-sectional association with albuminuria and glomerular filtration rateEuropean Heart Journal, 2012
- Association Between Cardiac Biomarkers and the Development of ESRD in Patients With Type 2 Diabetes Mellitus, Anemia, and CKDAmerican Journal of Kidney Diseases, 2011
- Predictors of fatal and nonfatal cardiovascular events in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia: An analysis of the Trial to Reduce cardiovascular Events with Aranesp (darbepoetin-alfa) Therapy (TREAT)American Heart Journal, 2011
- Cardiac Troponin T Measured by a Highly Sensitive Assay Predicts Coronary Heart Disease, Heart Failure, and Mortality in the Atherosclerosis Risk in Communities StudyCirculation, 2011
- Risk factors for mortality and ischemic heart disease in patients with long-term type 1 diabetesJournal of Diabetes and its Complications, 2010
- Determinants and prognostic implications of Cardiac Troponin T measured by a sensitive assay in Type 2 Diabetes MellitusCardiovascular Diabetology, 2010
- A Sensitive Cardiac Troponin T Assay in Stable Coronary Artery DiseaseNew England Journal of Medicine, 2009
- Prevalence and Determinants of Troponin T Elevation in the General PopulationCirculation, 2006
- Predictors of mortality in insulin dependent diabetes: 10 year observational follow up studyBMJ, 1996